EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Interplay of Cardiometabolic Syndrome Phenotypes and Cardiovascular Risk Indices in Patients Diagnosed with Diabetes Mellitus

Daniela Denisa Mitroi Sakizlian, Lidia Boldeanu iD, Adina Mitrea iD, Diana Clenciu iD, Ionela Mihaela Vladu iD, Alina Elena Ciobanu Plasiciuc, Andra Veronica Șarla, Isabela Siloși, Mihail Virgil Boldeanu iD, Mohamed-Zakaria Assani iD, Daniela Ciobanu

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26136227 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Daniela Denisa Mitroi Sakizlian und 10 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania. Hauptthemen laut MEDLINE: Metabolic Syndrome, Diabetes Mellitus, Type 2, Cardiovascular Diseases. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Medicine and Pharmacy of Craiova, Romania.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic syndrome (MetS) and its associated cardiometabolic phenotypes significantly contribute to the global burden of cardiovascular disease (CVD), especially in individuals with type 2 diabetes mellitus (T2DM) and prediabetes. This study aimed to explore the association between cardiometabolic phenotypes—specifically, metabolically unhealthy normal weight (MUHNW) and metabolically unhealthy obese (MUHO)—and various cardiovascular risk indices including the triglyceride-glucose (TyG) index and its derivatives, the atherogenic index of plasma (AIP), the cardiometabolic index (CMI), and the cardiac risk ratio (CRR). A total of 300 participants were evaluated (100 with prediabetes and 200 with T2DM). Anthropometric, biochemical, and lifestyle parameters were assessed and stratified across phenotypes. The results demonstrated that cardiovascular risk indices were significantly elevated in the MUHO compared to MUHNW phenotypes, with T2DM patients consistently exhibiting higher risk profiles than their prediabetic counterparts. TyG-derived indices showed strong correlations with BMI, waist–hip ratio (WHR), waist–height ratio (WHtR), and body fat percentage (%BF). The findings suggest that cardiometabolic phenotypes are more strongly associated with elevated cardiometabolic risk indices than body weight alone. These indices may enhance early risk stratification and intervention efforts. The study investigates the association of cardiometabolic phenotypes with surrogate cardiovascular risk indices, not direct CVD outcomes, However, the cross-sectional design and population homogeneity limit the generalizability of the results and preclude causal inference.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeDiabetes Mellitus, Type 2Cardiovascular DiseasesHumansMaleFemaleMiddle AgedPhenotypePrediabetic StateAdultObesityAgedBody Mass IndexTriglyceridesCardiometabolic Risk FactorsRisk FactorsHeart Disease Risk FactorsWaist-Hip RatioCross-Sectional StudiesBlood Glucose

Stichwörter der Autor:innen

atherogenic index of plasmacardiometabolic phenotypescardiometabolic riskcardiovascular riskmetabolic syndromeprediabetestriglyceride-glucose indextype 2 diabetes mellitus

Substanzen

TriglyceridesBlood Glucose

Autor:innen und Institutionen

  • Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Department of Microbiology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Department of Diabetes, Nutrition and Metabolic Diseases, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Department of Health and Motricity, Faculty of Medical and Behavioral Sciences, "Constantin Brâncuși" University of Târgu-Jiu, 210185 Târgu-Jiu, Romania.
  • Department of Immunology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Department of Internal Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.

ORCID-Profile: Lidia Boldeanu, Adina Mitrea, Diana Clenciu, Ionela Mihaela Vladu, Mihail Virgil Boldeanu, Mohamed-Zakaria Assani

Förderung

  • University of Medicine and Pharmacy of Craiova, Romania

Zitieren

APA

Mitroi Sakizlian, D. D., Boldeanu, L., Mitrea, A., Clenciu, D., Vladu, I. M., Ciobanu Plasiciuc, A. E., Șarla, A. V., Siloși, I., Boldeanu, M. V., Assani, M. Z., & Ciobanu, D. (2025). The Interplay of Cardiometabolic Syndrome Phenotypes and Cardiovascular Risk Indices in Patients Diagnosed with Diabetes Mellitus. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136227

Vancouver

Mitroi Sakizlian DD, Boldeanu L, Mitrea A, Clenciu D, Vladu IM, Ciobanu Plasiciuc AE, et al. The Interplay of Cardiometabolic Syndrome Phenotypes and Cardiovascular Risk Indices in Patients Diagnosed with Diabetes Mellitus. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136227

BibTeX
@article{MitroiSakizlian2025,
  author = {Mitroi Sakizlian, Daniela Denisa and Boldeanu, Lidia and Mitrea, Adina and Clenciu, Diana and Vladu, Ionela Mihaela and Ciobanu Plasiciuc, Alina Elena and Șarla, Andra Veronica and Siloși, Isabela and Boldeanu, Mihail Virgil and Assani, Mohamed-Zakaria and Ciobanu, Daniela},
  title = {The Interplay of Cardiometabolic Syndrome Phenotypes and Cardiovascular Risk Indices in Patients Diagnosed with Diabetes Mellitus},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26136227}
}
Kostenlos starten →